Safety Study of Remsima® (Infliximab) in Rheumatoid Arthritis Patients in Jordan

NCT03348046 · clinicaltrials.gov ↗

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Biosimilar Infliximab

Sponsor

Hikma Pharmaceuticals LLC

Collaborators

[object Object]